Gilead Sciences (GILD) Market Capitalization (2009 - 2026)
Gilead Sciences' Market Capitalization came in at $184.97 billion for Q3 2026, up 34.2% from $137.86 billion a year earlier and up 18.0% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Market Capitalization (2009 - 2026) Analysis & Trends
For FY2025, Gilead Sciences' Market Capitalization was $152.32 billion, up 32.3% from FY2024.
- Market Capitalization carries a five-year compound annual growth rate of 15.8% (FY2020 to FY2025).
- Going back by year, Market Capitalization was $115.09 billion in FY2024 (+14.0%), $100.94 billion in FY2023 (-5.7%), $107.05 billion in FY2022 (+17.6%) and $91.05 billion in FY2021 (+24.6%).
- The Q3 2026 figure represents the highest quarterly Market Capitalization in data going back to Q1 2009.
- Year-over-year, Market Capitalization has increased for nine consecutive quarters, with growth averaging 33.0% over the last eight quarters.
- The fastest year-over-year change in Market Capitalization over five years came in Q2 2025 (growth of 61.1%), and the weakest in Q1 2024 (a decline of 11.9%).
- Business Quant data shows GILD's Market Capitalization at $156.79 billion (Q2 2026), $173.1 billion (Q1 2026) and $152.32 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 184.97 Bn |
| Jun 30, 2026 | 156.79 Bn |
| Mar 31, 2026 | 173.10 Bn |
| Dec 31, 2025 | 152.32 Bn |
| Sep 30, 2025 | 137.86 Bn |
| Jun 30, 2025 | 137.70 Bn |
| Mar 31, 2025 | 139.50 Bn |
| Dec 31, 2024 | 115.09 Bn |
| Sep 30, 2024 | 104.46 Bn |
| Jun 30, 2024 | 85.49 Bn |
| Mar 31, 2024 | 91.27 Bn |
| Dec 31, 2023 | 100.94 Bn |
| Sep 30, 2023 | 93.45 Bn |
| Jun 30, 2023 | 96.11 Bn |
| Mar 31, 2023 | 103.55 Bn |
| Dec 31, 2022 | 107.05 Bn |
| Sep 30, 2022 | 77.36 Bn |
| Jun 30, 2022 | 77.51 Bn |
| Mar 31, 2022 | 74.61 Bn |
| Dec 31, 2021 | 91.05 Bn |
API Access
Gilead Sciences Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();